Additionally, combinatorial treatment with a STAT3 inhibitor and IFNα increases apoptosis in melanoma cells [116], suggesting that the activation of RIG-I in conjunction with cancer therapy could potentially improve its therapeutic efficacy. The gene discussed is RIGI; the disease is melanoma.